药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Indacaterol.
Trilostane
Azosemide
The risk or severity of hypokalemia can be increased when Indacaterol is combined with Azosemide.
Trilostane
Piretanide
The risk or severity of hypokalemia can be increased when Indacaterol is combined with Piretanide.
Trilostane
Terodiline
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Terodiline.
Trilostane
Macimorelin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Macimorelin.
Trilostane
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Deutetrabenazine.
Trilostane
Glasdegib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Glasdegib.
Trilostane
Ribociclib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ribociclib.
Trilostane
Ivabradine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ivabradine.
Trilostane
Lumefantrine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lumefantrine.
Trilostane
Artemether
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Artemether.
Trilostane
Asenapine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Asenapine.
Trilostane
Romidepsin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Romidepsin.
Trilostane
Vandetanib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vandetanib.
Trilostane
Iloperidone
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Iloperidone.
Trilostane
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tetrabenazine.
Trilostane
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Zuclopenthixol.
Trilostane
Temafloxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Temafloxacin.
Trilostane
Lithium cation
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lithium cation.
Trilostane
Halofantrine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Halofantrine.